ArticleLeukemia & lymphoma2024

Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia.

Kevin G Zablonski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.